coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    City Centre & Ancoats PCN, Manchester (LAD) · Health Inequalities Profile

    PCN U45992 · NHS Greater Manchester Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    43,533

    Registered population

    89.0% aged 18–64

    3.7%

    Aged 65+

    ICB 14.9% · England 17.9%

    33.9%

    Ethnic minority (non-White)

    14.7% Asian · England 9.6%

    20.0%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~7,012

    Core20 residents (est.)

    Resident basis; registered basis ~8,776 · see page 3

    2,174

    Hypertension register

    -2.07% in 3 yrs · England +5.60%

    449

    SMI register

    4.7% of Manchester (LAD)'s

    492

    COPD register

    Reviews +16.40% in 3 yrs

    Forecast to 2030

    2,222

    Hypertension patients, 2030

    +48 on today

    80.0%

    QRISK ≥20% on statins, 2030

    +3.10pp over 3 yrs

    1.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    564
    Asthma reviews and high prescribing.

    With 66.4% of 1,680 asthma patients reviewed, about 560 (564) lack a review alongside 3,341 items per 1,000 aged 5–19 (England 1,488).

    77.4%
    Pre-school booster coverage trails target.

    Age-5 4-in-1 booster coverage in Q1 2025/26 is 77.4% across 31 children (ICB 80.5%, England 80.9%), 17.6 pp below the 95.0% target.

    73.3%
    Lipid therapy and BP recording.

    Lipid therapy reaches 73.3% for QRISK ≥ 20% (England 63.6%) and 84.5% for CKD (England 70.3%), with 92.5% hypertension BP recording.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age patients make up 89.0% of the list, which may shape low crude prevalence

    Across 43,533 registered patients, 89.0% are aged 18–64, exceeding Manchester (68.9%), the ICB (63.3%) and England (62.7%). Conversely, 3.7% (1,620 patients) are aged 65+, below Manchester (9.6%), the ICB (14.9%) and England (17.9%). Children aged 0–17 comprise 7.2% (Manchester 21.4%, ICB 21.8%, England 19.6%). Census resident estimates show 66.1% White (Manchester 56.8%, ICB 76.4%, England 81.1%), alongside 14.7% Asian and 8.5% Black residents. Unverified projections suggest 3.7% list growth to 2030 (Manchester 2.6%, ICB 1.6%, England 2.3%). This younger demographic may explain low crude disease prevalence, though resident ethnicity does not reflect registered patients directly.

    Age profile

    0–177.2%
    18–6489.0%
    65+3.7%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White66.1%
    Asian14.7%
    Black8.5%
    Mixed5.4%
    Other5.2%

    Older people · falls rows are Manchester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Manchester LA)2,3572,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Manchester LA)1,2811,0219552024/25
    Falls deaths, all ages, per 100,000 (Manchester LA)26.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    A 20.0% PCN Core20 share masks a 27.5 pp spread across practices

    The PCN Core20 share is 20.0%, below Manchester (59.8%), the ICB (40.7%) and England (21.0%). Across practices, a 27.5 pp spread separates New Islington Medical Centre (31.8%, 4,158 estimated patients) and Ancoats Urban Village Medical Practice (27.3%, 3,924 estimated patients) from City Health Centre (4.3%, 694 estimated patients). Summed practice estimates of 8,776 registered patients diverge from the PCN resident deciles 1 and 2 count of 7,012. Proactive outreach should prioritise New Islington Medical Centre and Ancoats Urban Village Medical Practice, where deprivation is concentrated by both share and volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    New Islington31.8% · 4,158 patients
    Ancoats Urban27.3% · 3,924 patients
    City4.3% · 694 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    449

    SMI register

    1.09% recorded prevalence

    81

    Learning disability register

    0.20% recorded prevalence

    2

    Care homes, 115 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Manchester (LAD), Census 2021

    The PCN records 449 patients on the severe mental illness register (1.1%, Manchester 1.3%, England 1.0%) and 81 with learning disabilities (0.2%, England 0.6%). Catchment care homes contain 115 beds across 2 sites, though resident registrations are unconfirmed. The 449 patients on the severe mental illness register represent a larger cohort than the 81 patients recorded for learning disability.

    Severe mental illness: physical health checks

    Across 449 severe mental illness patients, 81.8% received a blood pressure check (England 83.4%), with City Health Centre at 74.7%, and 82.0% had BMI recorded (England 82.1%). Over three years, blood pressure check coverage rose 1.5 pp (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    2,174

    Hypertension register

    −2.07%

    Register growth, 3 yrs

    Manchester (LAD) +4.49% · England +5.60%

    +2.14pp

    BP control, under 80

    ≤140/90 · −0.01pp aged 80+

    +48

    More patients by 2030

    Forecast 2,222 (5.08%)

    Hypertension case-finding and control

    The PCN records 2,174 patients on its hypertension register, an unadjusted crude prevalence of 5.3% that is below Manchester (10.5%), the ICB (14.4%) and England (15.2%), with three-year prevalence falling 2.1% (England +5.6%). While 92.5% of recorded patients have a recent blood pressure check (England 90.0%), control to target in patients aged under 80 is 66.1% (England 67.8%), ranging from 65.1% at Ancoats Urban Village Medical Practice and 65.6% at City Health Centre to 68.1% at New Islington Medical Centre.

    Lipids and statins

    Lipid-lowering therapy coverage is strong across primary prevention groups: 73.3% of patients with QRISK ≥ 20% receive therapy against 63.6% in England, and CKD coverage reaches 84.5% against 70.3%.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202629,885£2.00£1.94£1.86£59,770
    Cardiovascular (all), 202539,176£2.72£3.15£3.33£106,559

    Across 29,885 lipid-regulating drug items prescribed in 2026, the PCN averaged £2.00 per item, compared to £1.86 in England, £1.94 in the ICB, and £2.21 in Manchester (LAD). This unit-cost difference represents £4,184 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +14.46%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.90%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 4.2% (1,680 patients) against England's 6.6%, with 66.4% reviewed in the last 12 months (England 65.7%), leaving an estimated 564 patients without a review. Prescribing reached 3,341 asthma management items per 1,000 aged 5-19 (England 1,488; Manchester 1,697). The COPD register includes 492 patients (1.2% prevalence vs England 1.9%), with three-year prevalence falling 5.2% (England +2.6%), while 80.3% were reviewed (England 76.4%).

    Cancer register and children's immunisation

    Cancer prevalence is 1.2% (503 patients) against England's 3.8% and Manchester's 2.2%. Among 3,155 registered children aged 0-17, immunisation coverage trails England and the 95.0% target: 6-in-1 at 12 months is 85.7% (England 91.0%), MMR dose 1 at 24 months is 83.0% (England 88.3%), and 4-in-1 at age 5 is 77.4% (England 80.9%), which is 17.6 pp below the 95.0% target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months85.7%

    England 91.0%

    6-in-1 complete primary course at 24 months91.5%

    England 92.2%

    MMR dose 1 at 24 months83.0%

    England 88.3%

    MMR dose 2 at age 590.3%

    England 82.8%

    4-in-1 pre-school booster at age 577.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB, 55.6% of cancers with a known stage (6,491 of 11,679 staged cancers; 70.8% known-stage share across 16,492 cancers in 2022) were diagnosed at stage 1 or 2, in line with England (55.3%) but below the 75.0% national ambition by 2028 (requiring about 2,270 extra early-stage cases a year). PCN breast screening coverage is 54.7% (Manchester 59.3%, ICB 68.8%, England 69.9%). Cervical screening coverage (aged 25-49) is 64.6% across the PCN (Manchester 57.2%, ICB 65.9%, England 66.8%) and 56.3% at City Health Centre. Staging data describes the wider ICB system, not PCN performance. Screening shortfalls indicate an opportunity for practices to strengthen proactive identification and recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% on the cancer 62-day referral to treatment standard (standard 85.0%), against England (71.2%), NHS Greater Manchester Integrated Care Board (75.7%), Northern Care Alliance NHS Foundation Trust (78.6%), and Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%). On the 28-day faster diagnosis standard, the trust reached 80.1% (standard 75.0%; ICB 79.5%, England 79.3%). For all diagnostic tests waiting 6+ weeks, the trust recorded 9.0%, below England (23.1%) and Northern Care Alliance NHS Foundation Trust (15.7%). Provider waits reflect acute capacity rather than PCN delivery.

    Pathways within standard (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2082.4879.5379.32
    31-day treatment (96%)92.5494.5496.2596.4992.50
    62-day referral to treatment (85%)72.8578.6576.7775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareEngland
    MRI11.685.090.0021.40
    CT14.664.100.189.92
    Echocardiography4.9131.480.0028.48
    Colonoscopy4.5140.041.5130.83
    Gastroscopy29.3536.485.4529.02
    All 15 DM01 tests8.9815.710.8023.14
    Community services activityManchester residentsGreater Manchester ICB
    Care contacts96,995573,310
    Referrals20,27094,470
    Patients with a contact31,040183,535

    Community services (residents of Manchester), Jun 2026 (provisional). In June 2026 (provisional), 92,690 community care activities were recorded for Manchester residents in experimental Community Services Statistics. Adults aged 65+ accounted for 43.3% of borough residents' contacts (42,015 of 96,995 contacts). These provisional experimental counts represent submitting providers across the local authority district rather than unique patients or PCN-level service activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 33.6 pp and vaccination achievement varies 84.1 pp across practices

    In 2025/26, clinical QOF achievement reached 99.0% at Ancoats Urban Village Medical Practice and 100.0% at both New Islington Medical Centre and City Health Centre (England 97.1%). Conversely, vaccination achievement spanned 84.1 pp, from 15.9% at Ancoats Urban Village Medical Practice to 100.0% at City Health Centre (England 55.2%), reflecting substantial delivery variation.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ancoats Urban9327.383.4%76.7%91.9%
    New Islington9331.881.1%75.7%88.5%
    City Health Centre714.349.8%66.9%73.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNManchester (LAD)AssetPCNManchester (LAD)
    Care homes (catchment)2 (115 beds)n/aSchools (catchment)60n/a
    Children's centres534Places of worship23289
    Libraries216Homelessness support (VCS)n/a1
    Primary schools (LA maintained)968Primary academies350
    Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Across the 1,680 asthma register, 66.4% had a review in the last 12 months (Manchester 67.0%, England 65.7%), leaving 564 (about 560) unreviewed alongside 3,341 items per 1,000 aged 5–19 (England 1,488). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Age-stratified dementia and register audit

    Dementia prevalence is 0.1% (39 patients) vs Manchester 0.4% and England 0.8% (unadjusted gap +134 to +302 across 43,533 patients), after falling 8.1% over three years (England +6.0%). For discussion: practices could run age-stratified clinical searches and cross-check care-home and social-care records to test for uncoded diagnoses. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 3

    Targeted childhood booster call and recall

    At age 5, 4-in-1 coverage is 77.4% (ICB 80.5%, England 80.9%), 17.6 pp below the 95.0% target (cohort 31); 24-month MMR1 is 83.0% (England 88.3%) and 12-month 6-in-1 is 85.7% (England 91.0%). Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Age-stratified clinical audit (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI blood pressure recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster call and recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Age-stratified dementia and register audit (p12)Dementia register · Dementia: QOF prevalence · Learning disability: QOF prevalence66.7% diagnosis ambition · 95% care plan 2027 · 75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · Targeted childhood booster call and recall (p12)4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · MMR dose 1 coverage at 24 months · 6-in-1 coverage at 12 months10YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15